Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines

Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines

Novel nanomedicines have been engineered to deliver molecules with therapeutic potentials, overcoming drawbacks such as poor solubility, toxicity or short half-life. Lipid-based carriers such as liposomes represent one of the most advanced classes of drug delivery systems. A Monomethyl Auristatin E...

Full description

Bibliographic Details
Main Authors: Ariana Abawi, Xiaoyi Wang, Julien Bompard, Anna Bérot, Valentina Andretto, Leslie Gudimard, Chloé Devillard, Emma Petiot, Benoit Joseph, Giovanna Lollo, Thierry Granjon, Agnès Girard-Egrot, Ofelia Maniti
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
liposomes
drug delivery
membrane fluidity
Monomethyl Auristatin E
Online Access:https://www.mdpi.com/1422-0067/22/8/4103

Internet

https://www.mdpi.com/1422-0067/22/8/4103

Similar Items